Role of liver fluke granulin in cholangiocarcinogenesis

肝吸虫颗粒蛋白在胆管癌发生中的作用

基本信息

  • 批准号:
    8707832
  • 负责人:
  • 金额:
    $ 24.35万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-21 至 2017-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Infection with the food-borne liver fluke parasites Opisthorchis viverrini and Clonorchis sinensis is a strong risk factor for cholangiocarcinoma (CCA), bile duct cancer, in Thailand, Laos and other locations in East Asia where infection is endemic. As determined by the World Health Organization's International Agency for Research on Cancer, no stronger link exists between human malignancy and a eukaryotic pathogen than that of CCA and liver fluke infection. CCA usually presents late, is a challenge for diagnosis, metastasizes readily and has high mortality - features highlighting the necessity to understand why and how infection with a food- borne parasite leads to a devastating liver cancer. The transformation from chronic infection with O. viverrini to CCA is multi-factorial, but one importan factor appears to be secretion into the bile ducts of parasite proteins with mitogenic properties, driving local proliferation of biliary and hepatic cells and creating a tumorigenic environment. We have identified a homologue of human granulin, a potent growth factor involved in cell proliferation and wound healing, in the excretory/secretory (ES) products of the parasite. O. viverrini granulin, termed Ov-GRN-1, is widely expressed in fluke tissues, including gut and tegument. Furthermore, Ov-GRN-1 locates in situ to the surface of biliary epithelial cells of hamsters experimentally infected with O. viverrini. Recombinant Ov-GRN-1 stimulates proliferation of murine fibroblasts and human CCA cell lines at nanomolar concentrations that can be inhibited by MAPK kinase inhibitors. Antibodies to Ov-GRN-1 inhibited the ability of O. viverrini ES products to induce proliferation of mammalian cell lines in vitro, indicating that Ov-GRN-1 is the major growth factor present in O. viverrini ES. This was the first report of a secreted growth factor from a parasitic worm that induces proliferation of host cells. Significantly, these new findings support a role for this fluke protein in establishment of a tumorigenic environment that may ultimately manifest as CCA. Here we plan to test this hypothesis with a particular emphasis on the role of Ov-GRN-1 in cell cycle progression and wound repair. We propose also to characterize transcriptional and translational responses of cholangiocytes and CCA cell lines to Ov-GRN-1 using proteomic and genomic microarray approaches to understand signaling and other pathways by which liver fluke granulin drives host cell proliferation. In addition, we propose to use gene silencing and vaccination of hamsters to determine whether Ov-GRN-1 is the major, or even sole, growth factor secreted by the parasite. These studies will determine whether Ov-GRN-1 is the Achilles' heel of this parasite that could be exploited as an anti-fluke and indeed anti-cancer vaccine.
描述(由申请人提供):在泰国、老挝和东亚其他地方,感染食源性肝吸虫(Opisthorchis viverrini)和华支睾吸虫是胆管癌(CCA)、胆管癌的一个很强的危险因素。根据世界卫生组织国际癌症研究机构的确定,人类恶性肿瘤与真核病原体之间没有比CCA和肝吸虫感染之间更强的联系。CCA通常出现较晚,诊断困难,容易转移,死亡率高,这些特点突出了了解食源性寄生虫感染为什么以及如何导致毁灭性肝癌的必要性。从慢性感染到CCA的转变是多因素的,但一个重要的因素似乎是具有有丝分裂特性的寄生虫蛋白分泌到胆管中,驱动胆道和肝细胞的局部增殖,并创造一个致瘤环境。我们

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Paul J Brindley其他文献

Programmed knockout mutation of liver fluke granulin , Ov-grn-1 , attenuates 1 virulence and impedes malignant transformation during chronic 2 opisthorchiasis 3 4 5
肝吸虫颗粒蛋白 , Ov-grn-1 的程序性敲除突变,减弱 1 毒力并阻止慢性 2 阿片吸虫病期间的恶性转化 3 4 5
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sujittra Chaiyadet;S. Tangkawattana;M. Smout;Wannaporn;Ittiprasert;V. Mann;Raksawan Deenonpoe;P. Arunsan;Alex;Loukas;Paul J Brindley;T. Laha
  • 通讯作者:
    T. Laha

Paul J Brindley的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Paul J Brindley', 18)}}的其他基金

Antibiotic selection for schistosome transgenesis
血吸虫转基因的抗生素选择
  • 批准号:
    8849840
  • 财政年份:
    2014
  • 资助金额:
    $ 24.35万
  • 项目类别:
Role of liver fluke granulin in cholangiocarcinogenesis
肝吸虫颗粒蛋白在胆管癌发生中的作用
  • 批准号:
    8371253
  • 财政年份:
    2012
  • 资助金额:
    $ 24.35万
  • 项目类别:
Role of liver fluke granulin in cholangiocarcinogenesis
肝吸虫颗粒蛋白在胆管癌发生中的作用
  • 批准号:
    9107394
  • 财政年份:
    2012
  • 资助金额:
    $ 24.35万
  • 项目类别:
Targeting parasite-host communication to combat liver fluke-induced bile duct cancer
针对寄生虫与宿主的通讯来对抗肝吸虫诱发的胆管癌
  • 批准号:
    10453668
  • 财政年份:
    2012
  • 资助金额:
    $ 24.35万
  • 项目类别:
Role of liver fluke granulin in cholangiocarcinogenesis
肝吸虫颗粒蛋白在胆管癌发生中的作用
  • 批准号:
    8549169
  • 财政年份:
    2012
  • 资助金额:
    $ 24.35万
  • 项目类别:
Targeting parasite-host communication to combat liver fluke-induced bile duct cancer
针对寄生虫与宿主的通讯来对抗肝吸虫诱发的胆管癌
  • 批准号:
    10226900
  • 财政年份:
    2012
  • 资助金额:
    $ 24.35万
  • 项目类别:
Role of liver fluke granulin in cholangiocarcinogenesis
肝吸虫颗粒蛋白在胆管癌发生中的作用
  • 批准号:
    8716242
  • 财政年份:
    2012
  • 资助金额:
    $ 24.35万
  • 项目类别:
Transduction of Schistosoma mansoni by pseudotyped retrovirus
假型逆转录病毒转导曼氏血吸虫
  • 批准号:
    7799460
  • 财政年份:
    2009
  • 资助金额:
    $ 24.35万
  • 项目类别:
Transduction of Schistosoma mansoni by pseudotyped retrovirus
假型逆转录病毒转导曼氏血吸虫
  • 批准号:
    7846579
  • 财政年份:
    2009
  • 资助金额:
    $ 24.35万
  • 项目类别:
Transduction of Schistosoma mansoni by pseudotyped retrovirus
假型逆转录病毒转导曼氏血吸虫
  • 批准号:
    7211226
  • 财政年份:
    2007
  • 资助金额:
    $ 24.35万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 24.35万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 24.35万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 24.35万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 24.35万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 24.35万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 24.35万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 24.35万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 24.35万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 24.35万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 24.35万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了